Treatment retention among patients randomized to buprenorphine/naloxone compared to methadone in a multi-site trial
Guardat en:
Hser, Y.I., et al., Treatment retention among patients randomized to buprenorphine/naloxone compared to methadone in a multi-site trial. Addiction, Vol. 109, no. 1 (2014), p. 79-89.
Ref.
196538
Localització:
SIIS R.696 Archivo
Palabras clave:
Alternativas, Buprenorfina, Dosis, Drogas ilegales, Drogodependencias, Efectos, Metadona, Opiáceos, Predicción, Programas de mantenimiento, Reducción de daños, Resultados, Retención, Tratamiento médico
Alternativas, Buprenorfina, Dosis, Drogas ilegales, Drogodependencias, Efectos, Metadona, Opiáceos, Predicción, Programas de mantenimiento, Reducción de daños, Resultados, Retención, Tratamiento médico
Ítems similars: Treatment retention among patients randomized to buprenorphine/naloxone compared to methadone in a multi-site trial
- Long-term outcomes after randomization to buprenorphine/naloxone versus methadone in a multi-site trial
- PREDICTORS OF OUTCOME FOR SHORT-TERM MEDICALLY SUPERVISED OPIOID WITHDRAWAL DURING A RANDOMIZED, MULTICENTER TRIAL OF BUPRENORPHINE-NALOXONE AND CLONIDINE IN THE NIDA CLINICAL TRIALS NETWORK DRUG AND ALCOHOL DEPENDENCE
- A longitudinal comparison of retention in buprenorphine and methadone treatment for opioid dependence in New South Wales, Australia
- Emerging adult age status predicts poor buprenorphine treatment retention
- TRANSFERRING METHADONE-MAINTAINED OUTPATIENTS TO THE BUPRENORPHINE SUBLINGUAL TABLET: A PRELIMINARY STUDY
- PHARMACOKINETICS OF THE COMBINATION TABLET OF BUPRENORPHINE AND NALOXONE